Macquarie Bank to advise on synchrotron

By Tanya Hollis
Friday, 12 April, 2002

Macquarie Bank has been appointed as financial adviser to the Victorian government's $157 million synchrotron project.

The bank, which is also the financial adviser to the government funded Biocomm Services, won out over seven tender applications for the contract.

Innovation Minister John Brumby said the appointment was another step towards the highly anticipated facility becoming a reality.

"The Australian Synchrotron Project is a key part of the Bracks government's Innovation portfolio, and will enable Victoria to capitalise on its emerging strengths in areas such as biotechnology, pharmaceuticals, environmental sciences and advanced manufacturing," Brumby said.

He said Macquarie's brief would include financial models covering "whole of life" costs of the project, the identification of potential users and commercial opportunities, risk profiles, funding options, private sector involvement and governance.

"The Australian Synchrotron Project is at a critical pre-construction phase, where careful and methodical planning is essential to ensure that future design and construction proceeds smoothly," Brumby said.

Last month, the minister announced site works would begin in September, with construction set to commence next year and the project pegged for completion in 2007.

Brumby said the appointment was the latest in a series of steps, which included the naming of Garry Seaborne as project director, the appointment of probity advisers and the establishment of international and national expert committees to help guide development of the facility.

Related News

Plug-and-play test evaluates T cell immunotherapy effectiveness

The plug-and-play test enables real-time monitoring of T cells that have been engineered to fight...

Common heart medicine may be causing depression

Beta blockers are unlikely to be needed for heart attack patients who have a normal pumping...

CRISPR molecular scissors can introduce genetic defects

CRISPR molecular scissors have the potential to revolutionise the treatment of genetic diseases,...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd